Xenetic Competitors
| XBIO Stock | USD 2.13 0.05 2.40% |
Xenetic Biosciences vs Abpro Holdings Correlation
Weak diversification
The correlation between Xenetic Biosciences and ABP is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and ABP in the same portfolio, assuming nothing else is changed.
Moving together with Xenetic Stock
Moving against Xenetic Stock
As of the 11th of February 2026, Return On Tangible Assets is likely to drop to -0.54. In addition to that, Return On Capital Employed is likely to drop to -0.66. At this time, Xenetic Biosciences' Total Current Assets are very stable compared to the past year. As of the 11th of February 2026, Non Currrent Assets Other is likely to grow to about 379.1 K, while Total Assets are likely to drop about 5.9 M.Xenetic Biosciences Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Xenetic Biosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Xenetic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Xenetic Biosciences does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Xenetic Stock performing well and Xenetic Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xenetic Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TTNP | 3.46 | 0.20 | 0.03 | 0.36 | 5.38 | 9.38 | 30.41 | |||
| ENSC | 5.07 | (2.15) | 0.00 | (1.47) | 0.00 | 10.64 | 31.20 | |||
| SNGX | 3.60 | (0.36) | 0.00 | (0.11) | 0.00 | 8.16 | 30.10 | |||
| OGEN | 3.48 | (0.72) | 0.00 | (0.40) | 0.00 | 7.32 | 24.70 | |||
| QLGN | 5.09 | (0.55) | 0.00 | 0.78 | 0.00 | 10.42 | 26.37 | |||
| CMND | 7.17 | (4.06) | 0.00 | 2.04 | 0.00 | 11.60 | 56.34 | |||
| KZIA | 8.13 | (0.22) | 0.01 | 0.04 | 10.26 | 14.69 | 78.79 | |||
| KALA | 6.12 | (0.59) | 0.00 | (0.32) | 0.00 | 12.28 | 59.48 | |||
| CANF | 5.03 | (0.59) | 0.00 | 0.43 | 0.00 | 10.40 | 38.42 | |||
| ABP | 5.03 | (1.69) | 0.00 | (0.81) | 0.00 | 11.84 | 39.11 |
Cross Equities Net Income Analysis
Compare Xenetic Biosciences and related stocks such as Titan Pharmaceuticals, Ensysce Biosciences, and Soligenix Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENSC | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | 2.1 M | 1.5 M | 56.8 K | (29.1 M) | (25 M) | (10.6 M) | (8 M) | (7.2 M) | (7.5 M) |
| SNGX | (1.2 M) | (2.4 M) | (4.2 M) | (10.1 M) | (6.7 M) | (7.8 M) | (3.2 M) | (7.1 M) | (8.9 M) | (9.4 M) | (17.7 M) | (12.6 M) | (13.8 M) | (6.1 M) | (8.3 M) | (7.4 M) | (7.8 M) |
| OGEN | (1.7 M) | (7.7 M) | (13.1 M) | (16.1 M) | (5.8 M) | (11.7 M) | (7 M) | (6.7 M) | (9.9 M) | (15.6 M) | (26.4 M) | (15.7 M) | (14.3 M) | (20.7 M) | (10.6 M) | (9.5 M) | (10 M) |
| CMND | (33.2 K) | (33.2 K) | (33.2 K) | (33.2 K) | (46.9 K) | (24.2 K) | (6.5 K) | (194.5 K) | (105.3 K) | (233.2 K) | (3.7 M) | (9.9 M) | (11.9 M) | (7.3 M) | (5.4 M) | (4.9 M) | (5.1 M) |
| KZIA | (17.1 M) | 1.3 M | (1 M) | (7.5 M) | (7.1 M) | (12.1 M) | (10.7 M) | (6 M) | (10.3 M) | (12.5 M) | (8.4 M) | (25 M) | (20.5 M) | (26.8 M) | (20.7 M) | (23.8 M) | (25 M) |
| KALA | (10.7 M) | (10.7 M) | (10.7 M) | (10.7 M) | (19.4 M) | (16.7 M) | (33.2 M) | (42.2 M) | (66.7 M) | (94.3 M) | (104.3 M) | (142.6 M) | (44.8 M) | (42.2 M) | (38.5 M) | (34.7 M) | (36.4 M) |
| CANF | (3.7 M) | (6.7 M) | (5.6 M) | (8.3 M) | (6.1 M) | (4.8 M) | (6.9 M) | (5 M) | (6.6 M) | (12.6 M) | (14.4 M) | (12.6 M) | (10.2 M) | (7.6 M) | (7.9 M) | (7.1 M) | (7.4 M) |
| ABP | (5.5 M) | (5.5 M) | (5.5 M) | (5.5 M) | (5.5 M) | (5.5 M) | (5.5 M) | (12.4 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (17.2 M) | (11.7 M) | (7.2 M) | (6.5 M) | (6.8 M) |
Xenetic Biosciences and related stocks such as Titan Pharmaceuticals, Ensysce Biosciences, and Soligenix Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Xenetic Biosciences financial statement analysis. It represents the amount of money remaining after all of Xenetic Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Xenetic Biosciences Competitive Analysis
The better you understand Xenetic Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Xenetic Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Xenetic Biosciences' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Xenetic Biosciences Competition Performance Charts
Five steps to successful analysis of Xenetic Biosciences Competition
Xenetic Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Xenetic Biosciences in relation to its competition. Xenetic Biosciences' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Xenetic Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Xenetic Biosciences' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Xenetic Biosciences, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Xenetic Biosciences position
In addition to having Xenetic Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Xenetic Biosciences Correlation with its peers. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Biotechnology sector continue expanding? Could Xenetic diversify its offerings? Factors like these will boost the valuation of Xenetic Biosciences. Anticipated expansion of Xenetic directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Xenetic Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.04) | Revenue Per Share | Quarterly Revenue Growth 0.672 | Return On Assets | Return On Equity |
Xenetic Biosciences's market price often diverges from its book value, the accounting figure shown on Xenetic's balance sheet. Smart investors calculate Xenetic Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Xenetic Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.